The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Apathy: a treatable syndrome
Abstract
Apathy occurs frequently in neuropsychiatric disorders both as a symptom of other syndromes and as a syndrome per se. Histories are presented of patients with a syndrome of apathy who showed clinically significant, sustained benefit from pharmacological treatment. Etiologies included non-Alzheimer's frontal lobe dementia, cerebral infarction, intracranial hemorrhage, alcoholism, and traumatic brain injury. Agents included amantadine, amphetamine, bromocriptine, bupropion, methylphenidate, and selegiline. These histories support the suggestion that apathy is a discriminable dimension of behavior having its own pathophysiology and implications for psychiatric care. They raise the possibility of treatment for many patients previously thought untreatable. Studying the treatment of apathy may contribute to the clinical care and scientific understanding of neuropsychiatric disorders throughout the life span.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
Apathy and Indifference in Patients on Fluvoxamine: and Fluoxetine
HOEHN-SARIC, R., LIPSEY, J. R., & McLEOD, D. R. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199010000-00007 · Cited by 156
Cited by
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
Chaudhuri, K. R., & Schapira, A. H. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70068-7 · Cited by 1,738
Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., Paulsen, J. S., & Litvan, I. (1998) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.10.3.314 · Cited by 678
Frontal-subcortical circuitry and behavior
Bonelli, R. M., & Cummings, J. L. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/rbonelli · Cited by 612
Methylphenidate: Its Pharmacology and Uses
CHALLMAN, T. D., & LIPSKY, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 553
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00019-8 · Cited by 549
Deep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Landes, A. M., Sperry, S. D., Strauss, M. E., & Geldmacher, D. S. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49282.x · Cited by 379
The nosological position of apathy in clinical practice
Starkstein, S. E., & Leentjens, A. F. G. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136895 · Cited by 371
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366
Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour
Brown, R. G., & Pluck, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01626-x · Cited by 303
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299
Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1173 · Cited by 281
Lavretsky, H., Ballmaier, M., Pham, D., Toga, A., & Kumar, A. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3180325a16 · Cited by 143
Apathy in schizophrenia: clinical correlates and association with functional outcome
Kiang, M., Christensen, B. K., Remington, G., & Kapur, S. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00433-4 · Cited by 118
Pharmacological interventions for apathy in Alzheimer's disease
Ruthirakuhan, M. T., Herrmann, N., Abraham, E. H., Chan, S., & Lanctôt, K. L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012197.pub2 · Cited by 113
Agay, N., Yechiam, E., Carmel, Z., & Levkovitz, Y. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1853-4 · Cited by 101
Hahn, C., Lim, H.-K., Won, W. Y., Ahn, K. J., Jung, W.-S., & Lee, C. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053493 · Cited by 76
Bolling, M. Y., & Kohlenberg, R. J. (2004) · Psychotherapy and Psychosomatics · doi:10.1159/000080392 · Cited by 74
Assessing apathy: The use of the Apathy Evaluation Scale in first episode psychosis
Faerden, A., Nesvåg, R., Barrett, E. A., Agartz, I., Finset, A., Friis, S., Rossberg, J. I., & Melle, I. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.09.002 · Cited by 73
Kamat, R., Brown, G. G., Bolden, K., Fennema-Notestein, C., Archibald, S., Marcotte, T. D., Letendre, S. L., Ellis, R. J., Woods, S. P., Grant, I., et al. (2014) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2014.950636 · Cited by 47
Benztropine in the Treatment of Venlafaxine-Induced Sweating
Garber, A., & Gregory, R. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0407e · Cited by 24
Metadata
- Venue
- The Journal of Neuropsychiatry and Clinical Neurosciences
- Published
- 1995-02-01
- Volume
- 7
- Issue
- 1
- Pages
- 23-30
- ISSN
- 0895-0172 (ISSN-L)
- 1545-7222
- OpenAlex
- W2403187759
- Cited by
- 231
- References
- 2
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.